Pasithea Therapeutics (KTTA) Accounts Payables (2021 - 2024)
Historic Accounts Payables for Pasithea Therapeutics (KTTA) over the last 4 years, with Q3 2024 value amounting to $660397.0.
- Pasithea Therapeutics' Accounts Payables fell 6467.44% to $660397.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $660397.0, marking a year-over-year decrease of 6467.44%. This contributed to the annual value of $2.6 million for FY2023, which is 7229.46% up from last year.
- Per Pasithea Therapeutics' latest filing, its Accounts Payables stood at $660397.0 for Q3 2024, which was down 6467.44% from $1.4 million recorded in Q2 2024.
- In the past 5 years, Pasithea Therapeutics' Accounts Payables registered a high of $2.6 million during Q4 2023, and its lowest value of $433684.0 during Q1 2022.
- Its 4-year average for Accounts Payables is $1.3 million, with a median of $1.4 million in 2024.
- In the last 5 years, Pasithea Therapeutics' Accounts Payables surged by 23377.74% in 2023 and then plummeted by 6467.44% in 2024.
- Over the past 4 years, Pasithea Therapeutics' Accounts Payables (Quarter) stood at $447280.0 in 2021, then surged by 231.2% to $1.5 million in 2022, then skyrocketed by 72.29% to $2.6 million in 2023, then tumbled by 74.13% to $660397.0 in 2024.
- Its Accounts Payables stands at $660397.0 for Q3 2024, versus $1.4 million for Q2 2024 and $2.4 million for Q1 2024.